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Abstract
Background: Hyperammonemia is a medical condition described as increased or elevated serum ammonia levels.
High serum levels of ammonia can cause neurotoxicity. Sudden onset severe hyperammonemia may cause severe
encephalopathy with brain damage. It can result in cerebral edema, emesis, seizures, hypotonia, and death. We report
a young postpartum woman who had a sudden rise in serum ammonia levels after vaginal delivery.
Case presentation: A 24-year-old, married, postpartum Pakistani woman was admitted to the intensive care unit
through the emergency department, with complaints of fever, severe abdominal pain with distension, and altered
levels of consciousness. The patient had a medical history of spontaneous vaginal delivery 2 weeks before this hospital admission, after which she gradually developed the above symptoms. However, the patient’s past medical history
was unremarkable with no hepatic disease, but her investigations revealed a progressive rise in serum ammonia levels. In the intensive care unit, she developed generalized tonic–clonic seizures. This was followed by a coma, tonsillar
herniation, and death.
Conclusion: Postpartum hyperammonemia is a rare entity. It is a critical illness and must be evaluated for underlying metabolic disorders. Early diagnosis and treatment may result in better outcomes and reduced mortality among
postpartum women with hyperammonemia.
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Introduction
Ammonia is a metabolite produced in the human body as
a result of protein and amino acid breakdown. Ammonia
also aids in the synthesis of amino acids and maintains
acid–base balance. However, high levels of ammonia can
cause severe toxicity [1, 2].
Hyperammonemia refers to an elevated or increased
level of serum ammonia in the body. High levels in the
serum may result in neurotoxicity [2]. Sudden-onset
severe hyperammonemia may cause severe encephalopathy with brain damage. Furthermore, cerebral edema,
emesis, seizures, hypotonia, and death can occur [2, 3].
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However, a chronic, mild rise in ammonia levels can
cause neuropsychiatric problems, such as delirium and
behavioral changes. Survivors of severe neonatal hyperammonemia suffer structural brain damage [3].
Hyperammonemia is present among adult patients
with complicated liver disease. The metabolic disorders
causing hyperammonemia include deficiencies of urea
cycle enzymes, citrin, and pyruvate carboxylase [4, 5]. In
critical care units, most patients with hyperammonemia
present with an acute rise in ammonia, which requires
immediate management to prevent brain damage and
death. The other causes of hyperammonemia include
ornithine carbamoyltransferase deficiency, hematologic
malignancy, and the side effects of valproic acid and
5-fluorouracil (5-FU) [5].
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Here we report a case of young postpartum women
who had a sudden rise in ammonia levels after vaginal
delivery.

Case presentation
A 24-year-old postpartum Pakistani woman was admitted to the intensive care unit (ICU) of a well-equipped
private tertiary care hospital through the emergency
department. The presenting complaints were fever,
severe abdominal pain with distension about 2 weeks
after delivery, and altered levels of consciousness (ALOC)
presenting 2 days before admission. She had a high-grade
fever, undocumented, without chills and rigors, relieved
with medications, and associated with severe generalized
abdominal pain. Abdominal pain was sharp, constant,
had no aggravating or relieving factors, and was associated with bloating and distension. Over the past 2 days
she developed altered mentation in which she was talking
inappropriately, not recognizing close family members,
and getting drowsier. She was primigravida and had a
spontaneous vaginal delivery 2 weeks before this hospital
admission, after which she gradually developed the above
symptoms. However, she did not have a significant medical history. Family history was also unremarkable. On
physical examination, she was pale, tachycardiac (heart
rate was 120 bpm), and tachypneic (respiratory rate was
32 breaths/minute). She had a Glasgow Coma scale score
of 8/15, so was electively intubated. Her motor examination was unremarkable, while the rest of the neurological exam cannot be accessed due to low mentation. Her
cardiovascular and respiratory examinations were insignificant. In the abdomen, examination revealed a soft,
distended abdomen with hepatomegaly and positive
shifting dullness. There was no tenderness in the abdomen. An investigation was then conducted to determine
the cause of her symptoms. Her initial laboratory investigations are presented in Table 1. Based on her high
polymorphic leukocytosis on cerebrospinal fluid (CSF)
analysis, it was suspected that she had acute bacterial
meningitis. Hence, empirical antibiotics in meningitic
doses were given. Despite treatment, her central nervous system examination showed no improvement. She
remained comatose throughout her ICU stay.
Moreover, she developed generalized tonic–clonic
seizures. Levetiracetam was initiated to control seizures. Her blood biochemistry showed a persistent rise
in serum ammonia levels. Three ammonia level assessments showed a gradual increase from 695 µ/dL, 770 µ/
dL, to 1300 µ/dL in 3 days (Fig. 1). Ultrasound of the liver
showed normal liver size, shape, and echo texture, with
no evidence of chronic liver disease.
She was kept on a high protein diet to prevent hyperammonemia. A medication to neutralize ammonia was
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Table 1 Laboratory investigation of the patient
Complete blood count

Hemoglobin: 10 mg/dL
Hematocrit: 32%
Total leukocyte count: 10,000/mL
Platelets count: 51,000

Liver function tests

Total bilirubin : 1.7 mg/dL
Alanine transaminase: 15 IU/L
Aspartate aminotransferase: 38 U/L
Gamma-glutamyl transferase: 16 IU/L
Alkaline phosphatase: 35 IU/L

Enzymes

Trop-I : Negative
Procalcitonin : 8 ng/mL
Creatinine phosphokinase: 391 IU/L

Screening for infections

Malaria parasite microscopy: Negative
Dengue ELISA : Negative
HIV ELISA: Negative
Hepatitis B antibody: Nonreactive
Hepatitis C antibody: Nonreactive

CFS examination

Protein levels: 25 mg/dL
Glucose levels: 72 mg/dL
Chloride levels: 136 mg/100 mL
Leukocyte count 19 cells/µL (neutrophil 80% and lymphocyte 20%)

Fig. 1 Persistent rise in serum ammonia levels

not offered because of nonavailability. She purged with
2–3 stools per day. Lactulose and l-carnitine were given.
The nephrology team was taken on board and she had a
session of hemodialysis. On the third day of admission,
her pupil got fixed. A magnetic resonance imaging of
the brain was then done that showed tonsillar herniation
(Fig. 2).
Despite conservative management and all efforts to
control hyperammonemia, she suffered permanent brain
damage. Postpartum examination was not performed.
We did not perform any tissue biopsy. Genetic testing is
not available at our institution. The patient’s family was
informed about the guarded prognosis and they decided
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Fig. 2 MRI brain showing tonsillar herniation via black arrows on sagital plane (A, B) and compression of ventricle with slight deviation of
cereberum to left is shown via arrows on axial plane (C, D)

to withdraw support. The patient succumbed to death
after being removed from the ventilator on 4th day of the
hospital stay.

Discussion
We report a case of a young woman with rapidly progressive hyperammonemia of unknown origin.
Her initial diagnostic workup failed to reveal any relevant etiology including chronic liver disease. Moreover,
she was treated for suspected bacterial meningitis but she
never responded to the treatment and remained comatose. Furthermore, a rapid rise in serum ammonia level
led to further brain damage, which resulted in tonsillar
herniation and death. Previously published literature has
reported ornithine carbamoyltransferase (OTC) deficiency, hematologic malignancy, and the side effects of
valproic acid and 5-fluorouracil (5-FU) as the cause of
unexplained hyperammonemia in the absence of hepatic
dysfunction [6–9]. In this case, the patient was never
given any antiepileptic before ICU admission and in ICU
stay she received levetiracetam and lacosamide instead of
valproic acid to control the epileptic seizures. Hence, this
rules out any possible role of valproic acid in raising her
serum ammonia levels as supported by the previous evidence [9, 10].
Moreover, the patient had no history of any metabolic
disorder so she was not investigated to rule out hyperglutaminemia, or orotic aciduria to diagnose ornithine

carbamoyltransferase (OTC) deficiency. However, a
previous case supports the possibility of undiagnosed
ornithine carbamoyltransferase deficiency resulting in
unexplained postpartum hyperammonemia [11]. However, another possible explanation of unexplained postpartum hyperammonemia, in this case, could be
enzymatic deficiencies and disorders of the urea cycle
that rarely manifest clinically in adulthood until the body
goes through physiological stresses or increased catabolism such as during surgery, delivery, or trauma [7, 12,
13]. The postpartum period is a highly catabolic state and
unexplained postpartum hyperammonemia is previously
reported as a rare outcome among postpartum women
with urea cycle enzyme deficiency [13]. Nonhepatic
hyperammonemia is now becoming common, with most
causes being drug-induced or a genetic inborn error of
metabolism. However, it is important to note that genetic
testing is not frequently available or done. Further studies and cases are required to support this diagnosis of
nonhepatic and non-drug-induced hyperammonemia,
especially when genetic predisposition is not known or
genetic workup is not available.
Despite these hypotheses, we recommend further
research into diagnosing and managing these patients.
This case report has blown our minds and forced us
to evaluate and study postpartum hyperammonemia.
Though cases had been reported in the past, in a third
world country such as Pakistan, we should be clinically
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vigilant about this entity. We have limited diagnostic and
therapeutic options in our country, but hyperammonemia needs to be corrected aggressively to avoid death.
Our case had certain limitations. No genetic testing
facilities are available at our center. After experiencing
an acute deterioration within 3–4 days, we were unable
to investigate for an enzymatic deficiency. We did not
offer ammonia scavenger therapy to the patient as it is
not available in our country. But this case has forced us
to think out of the box. Postpartum hyperammonemia is
an uncommon illness and requires medical attention for
early identification and prompt management.

Conclusion
Postpartum hyperammonemia is a rare entity. It is a critical illness and underlying metabolic disorders must be
evaluated. Early diagnosis and treatment may result in
better outcomes and reduced mortality among postpartum women with hyperammonemia.
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